News In Brief
This article was originally published in The Gray Sheet
Orthofix settles foreign bribery charges. Cardiosolutions wins $8 million investment for mitral valve technology. OraSure plans $75 million stock offering. More news in brief.
You may also be interested in...
Federal and state regulatory news updates.
Orthofix pleaded guilty to the felony of obstructing a federal audit and also has settled civil charges with the federal government. But the settlement will not be final until it is approved by a federal judge, who postponed his decision last week.
Firm gains PMA approval for OraQuick July 3, making it the first available HIV test that can be performed entirely in the home by untrained users.